1. Introduction
===============

*Astragalus* species are among the most widely distributed in northern temperate regions and tropical African mountains \[[@B1-molecules-18-03725]\]. Five species have been identified in Korea and the primary parts used for medicinal purposes, are cylindrical, but not usually branched, measure around 30--90 cm in length, and are covered with a tough, yellowish-brown skin with a sweet white inner pulp \[[@B2-molecules-18-03725]\]. Radix astragali, the dried root of *Astragalus membranaceus* (FISCH.) BGE., known as Huangqi in China and Korea, is one of the most widely used medicinal herbs prescribed in many Chinese formulas to reinforce "Qi" (the vital energy) \[[@B3-molecules-18-03725]\]. Studies of its pharmacological and clinical uses have demonstrated that Astragali Radix has many biological functions, including hepatoprotection \[[@B4-molecules-18-03725]\], neuroprotection \[[@B5-molecules-18-03725]\], cardiotonic \[[@B6-molecules-18-03725]\], anti-aging activity \[[@B7-molecules-18-03725]\], anti-cancer effects \[[@B8-molecules-18-03725]\], and anti-inflammatory effects \[[@B9-molecules-18-03725]\]. *Astragalus* species are rich in cycloartane-type triterpene glycosides that possess diverse biological activities. Some cycloartane triterpene glycosides have been shown to have antitumor activity \[[@B10-molecules-18-03725]\]. Astragaloside IV, a cycloartane triterpene glycoside extracted from Radix Astragali, has a broad range of pharmacological properties, including antiapoptotic \[[@B11-molecules-18-03725]\], anti-inflammatory and antihypertensive \[[@B12-molecules-18-03725]\] effects.

As part of our efforts to isolate the chemical constituents of Astragali Radix to evaluate *A. membranaceus* qualitatively, we report herein on the isolation of a new minor saponin, agroastragaloside V (**1**), obtained from the roots of *A. membranaceus* cultivated in Korea, together with four known compounds **2**--**5**, and the structural determination of these substances using extensive spectroscopic methods. Several previous studies have provided immune stimulant effects of several cycloartane-type triterpene glycosides and the extracts on macrophage activation and expression of inflammatory cytokines were investigated from *Astragalus* species \[[@B9-molecules-18-03725],[@B12-molecules-18-03725]\]. Therefore, isolated compounds **1**--**5** were evaluated for anti-inflammatory activities through the measurement of nitrite, a soluble oxidation product of nitric oxide (NO), in lipopolysaccharide (LPS)-induced RAW 254.7 macrophage cells.

2. Results and Discussion
=========================

A 80% methanolic extract of dried roots of *A. membranaceus* was suspended in H~2~O and extracted with EtOAc, and then *n*-BuOH. The EtOAc soluble fraction was concentrated under reduced pressure to produce a residue which was then subjected to multiple chromatographic steps using silica gel, reversed-phase C18, and Sephadex LH-20, yielding the compounds **1**--**5** ([Figure 1](#molecules-18-03725-f001){ref-type="fig"}).

![Chemical structures of isolated compounds **1**--**5**.](molecules-18-03725-g001){#molecules-18-03725-f001}

Compound **1**, was obtained as an amorphous white powder from MeOH. High-resolution (HR) FAB-MS exhibited an ion peak for \[M−H\]^−^ at *m*/*z* 811.4777, which is compatible with the molecular formula C~43~H~72~O~14~. The IR spectrum of **1** showed the presence of a hydroxyl group (3433 cm^−1^) and an ester carbonyl group (1,724 cm^−1^). The ^1^H-NMR spectrum of **1** ([Table 1](#molecules-18-03725-t001){ref-type="table"}) revealed the presence of a cyclopropane methylene group with signals at δ~H~ 0.17 (1H, d, *J* = 4.0 Hz) and 0.53 (1H, d, *J* = 4.0 Hz) and also contained signals for six tertiary methyl groups at δ~H~ 0.95, 1.28, 1.38, 1.41, 1.43, and 1.78, and for one acetyl methyl group (δ~H~ 2.03) which were correlated in HSQC with carbon signals at δ~C~ 19.9, 16.6, 18.6, 25.7, 26.5, 28.3 and acetyl (δ~C~ 21.2), respectively. A secondary methyl group at δ~H~ 1.07 (3H, d, *J* = 6.4 Hz) and at δ~C~ 18.3, and four oxygen bearing methine proton signals at δ~H~ 4.48 (ddd, *J* = 8.0, 8.0, 5.2 Hz), 3.53 (ddd, *J* = 9.5, 9.5, 4.5 Hz), 3.41 (dd, *J* = 10.5, 2.2 Hz) and 3.23 (dd, *J* = 11.3, 4.0 Hz), which were indicative of secondary alcoholic functions ([Table 1](#molecules-18-03725-t001){ref-type="table"}), were readily noticed in the ^1^H-NMR spectrum. Furthermore, the ^1^H-NMR spectrum of **1** clearly showed two anomeric doublets at δ~H~ 4.77 (*J* = 7.6 Hz), and 4.96 (*J* = 7.2 Hz) in the downfield region, indicating of the presence of two *β*-linked sugars. This was supported by the ^13^C-NMR spectrum, which showed two anomeric carbon signals at δ~C~ 104.7 and 105.2. The chemical shifts of the individual protons of the two sugar units were revealed from a combination of 2D-COSY spectral analyses, and ^13^C chemical shifts of their relative attached carbons were assigned unambiguously from the HSQC and HMBC experiments which led to the identification of a *β*-xylopyranosyl unit and a *β*-glucopyranosyl unit. The sites of attachment of the xylose and glucose moieties of **1** were determined by HMBC experiment to be at C-3 and C-6, respectively. In the HMBC spectrum, the first anomeric proton signal at δ~H~ 4.77 (H-1\') showed long range correlation with the carbon at δ~C~ 89.0 (C-3). Also the second anomeric proton signals at δ~H~ 4.96 (H-1\") showed long-range correlation with the carbons at δ~C~ 79.1 (C-6), respectively. Consequently, xylose and glucose should be attached to the hydroxyl groups at C-3 and C-6. The relative configuration of OH-6 was confirmed by a NOESY experiment, which showed a correlation between H-6 and H-28, H-19a, as well as H-8. These NOE correlations indicated that the oxygen at C-6 is *α*-oriented. In the ^1^H-NMR spectrum, signals at 2.03 (3H, s), and ^13^C-NMR signals at 170.0, showed the presence of an acetoxyl group in **1**. The NMR data of the acetoxyl moiety of **1** were in good agreement with those reported for agroastagaloside II (**3**) \[[@B13-molecules-18-03725],[@B14-molecules-18-03725]\]. Also, the cross peak between the oxygenated methine proton signal of xylose (H-2\') and the ester carbon signal (δ~C~ 170.0) suggested that the acetyl group was linked to the hydroxyl of C-2\' of xylose ([Figure 2](#molecules-18-03725-f002){ref-type="fig"}) in the HMBC spectrum. This was confirmed by the down-field shifts of the carbon (δ~C~ 75.7) and proton signal (δ~H~ 5.52, H-2\') owing to the esterification effect. The ^13^C-NMR spectrum of **l** displayed a total of 43 carbon signals. Based on a DEPT experiment, the HSQC spectrum, and a comparison with the ^13^C-NMR data of the related agroastagaloside II (**3**), all the signals could be assigned ([Table 2](#molecules-18-03725-t002){ref-type="table"}). These data were similar to agroastagaloside II (**3**) with the exception of the proton and carbon resonances for the lack of an oxygenated methine moiety at the C-16 position, respectively. The methylene signals due to C-16 in **1** were replaced by those of an oxygenated methine (δ~H~ 4.72 and δ~C~ 72.1) in agroastagaloside II (**3**) \[[@B14-molecules-18-03725]\]. The molecular weight of **1** was 16 Da less than that of agroastagaloside II (**3**), indicating the presence of one less hydroxyl group. This conclusion was also supported by the HMBC spectrum, which showed ^2^*J*, ^3^*J*, and long range correlation between the proton signal of H-17 (δ~H~ 1.51) and the carbon signals of C-13 (δ~C~ 45.8), C-16 (δ~C~ 28.7), C-20 (δ~C~ 28.6), C-18 (δ~C~ 18.6) and C-21 (δ~C~ 18.3) ([Figure 2](#molecules-18-03725-f002){ref-type="fig"}). The [d]{.smallcaps}-configurations of xylose and glucose units were established after hydrolysis of **1** followed by GC analysis \[[@B15-molecules-18-03725]\]. Finally, the structure of **1** was determined to be 3-*O*-*β*-(2\'-*O*-acetyl)-[d]{.smallcaps}-xylopyranosyl-6-*O*-*β*-[d]{.smallcaps}-glucopyranosyl-(24*S*)-3*β*,6*α*,24*α*,25-tetrahydroxy-9,19-cyclolanostane, and named agroastragaloside V. Comparisons of NMR and MS data for the known compounds **2**--**5** with reported values led to their identification as agroastragaloside I (**2**) \[[@B16-molecules-18-03725]\], agroastragaloside II (**3**) \[[@B14-molecules-18-03725]\], isoastragaloside II (**4**) \[[@B13-molecules-18-03725]\] and astragaloside IV (**5**) \[[@B16-molecules-18-03725]\], respectively ([Figure 1](#molecules-18-03725-f001){ref-type="fig"}).
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###### 

^1^H- (400 MHz) and ^13^C-NMR (100 MHz) data of compound **1** (in pyridine-*d~5~*, *δ* in ppm, *J* in Hz) ^a^.

  No.   δ~H~                                                  δ~C~ (DEPT)    No.              δ~H~                                                                      δ~C~ (DEPT)
  ----- ----------------------------------------------------- -------------- ---------------- ------------------------------------------------------------------------- --------------
  1     1.27 ^b^, 1.55 ^b^, m                                 32.1 (CH~2~)   23               1.68 ^b^, 1.96 ^b^, m                                                     27.9 (CH~2~)
  2     1.68 ^b^, 1.94 ^b^, m                                 30.0 (CH~2~)   24               3.91, brd, *J* = 10.8                                                     77.1 (CH)
  3     3.39, dd, *J* = 4.4, 11.6                             89.0 (CH)      25               \-                                                                        72.5
  4     \-                                                    42.3           26               1.43, s                                                                   25.7 (CH~3~)
  5     1.93, d, *J* = 8.8                                    52.5 (CH)      27               1.41, s                                                                   26.5 (CH~3~)
  6     3.78, ddd, *J* = 4.4, 9.6, 9.6                        79.1 (CH)      28               1.78, s                                                                   28.3 (CH~3~)
  7     1.82, 2.25, m                                         34.5 (CH~2~)   29               1.28, s                                                                   16.6 (CH~3~)
  8     1.90, m                                               45.8 (CH)      30               0.95, s                                                                   19.9 (CH~3~)
  9     \-                                                    21.5           1\'              4.77, d, *J* = 7.6                                                        104.7 (CH)
  10    \-                                                    28.7           2\'              5.52, dd, *J* = 8.0, 8.0                                                  75.7 (CH)
  11    1.15, 1,89 ^b^, m                                     26.3 (CH~2~)   3\'              4.15 ^b^, m                                                               76.3 (CH)
  12    1.64 ^b^, 2.35 ^b^, m                                 33.2 (CH~2~)   4\'              4.14 ^b^, m                                                               71.4 (CH)
  13    \-                                                    45.8           5\'              4.27 ^b^, m, H-5\'a 3.62, dd, *J* = 9.6, 11.6, H-5\'b                     67.1 (CH~2~)
  14    \-                                                    46.9           1\'\'            4.96, d, *J* = 7.2                                                        105.2 (CH)
  15    1.45 ^b^, 1.66 ^b^, m                                 30.0 (CH~2~)   2\'\'            4.00, dd, *J* = 8.0, 8.0                                                  75.6 (CH)
  16    1.33 ^b^, 1.54 ^b^, m                                 28.7 (CH~2~)   3\'\'            4.29, m                                                                   79.1 (CH)
  17    1.51 ^b^, m                                           49.7 (CH)      4\'\'            4.10, dd, *J* = 8.8, 8.8                                                  72.0 (CH)
  18    1.38, s                                               18.6 (CH~3~)   5\'\'            3.88, m                                                                   78.1 (CH)
  19    0.17, d, *J* = 4.0, H-19a 0.53, d, *J* = 4.0, H-19b   28.4 (CH~2~)   6\'\'            4.42, dd, *J* = 2.4, 11.2, H-6\'\'a 4.29, dd, *J* = 3.6, 11.2, H-6\'\'b   63.2 (CH~2~)
  20    2.39 ^b^, m                                           28.6 (CH)      [C]{.ul}OCH~3~   \-                                                                        170.0
  21    1.07, d, *J* = 6.4                                    18.3 (CH~3~)   [C]{.ul}OCH~3~   2.03, s                                                                   21.2 (CH~3~)
  22    1.40, 1.99 ^b^, m                                     33.0 (CH~2~)                                                                                              

^a^ Assignments were confirmed by ^1^H-^1^H COSY, HSQC, and HMBC. ^b^ Signals are unclear due to overlapping.

![Key ^1^H-^1^H COSY (bold dash) and HMBC (blue arrow) correlations of compound **1**.](molecules-18-03725-g002){#molecules-18-03725-f002}

Previous studies have already reported on the anti-inflammatory effects of components obtained from *A. membranaceus* \[[@B9-molecules-18-03725],[@B12-molecules-18-03725]\]. Thus, we also investigated the inhibitory effects of compounds **1**--**5** on NO production by using the Griess reaction to measure nitrite, a soluble oxidation product of NO, in the culture medium of LPS-induced RAW 264.7 macrophages. As shown in [Table 2](#molecules-18-03725-t002){ref-type="table"}, compounds **1**--**5** inhibited NO production with IC~50~ values in the range of 1.38 to 4.70 μM, respectively. Some cell toxicity was observed in cells treated with compounds **2**, **3** and **4**, whereas other compounds had no influence on cell viability.
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###### 

Inhibitory effects of compounds **1**--**5** against LPS-Induced NO production in RAW 264.7 macrophage cells.

  Compound           IC~50~ (μM) ^a^   cell viability (%) ^b^
  ------------------ ----------------- ------------------------
  1                  1.85 ± 0.24       93.15 ± 6.96
  2                  1.38 ± 0.15       54.54 ± 1.21
  3                  2.31 ± 0.47       47.56 ± 3.40
  4                  4.70 ± 1.77       68.98 ± 1.82
  5                  2.09 ± 0.27       94.42 ± 4.33
  Caffeic acid ^c^   0.83 ± 1.15       82.20 ± 1.64

^a^ The IC~50~ value of each compound was defined as the concentration (μM) that caused 50% inhibition of NO production in LPS-activated RAW 264.7 macrophage cells. Cells were pretreated for 1 h with compounds before stimulation with LPS (1 μg/mL) for 7 h; ^b^ Cell viability indicates mean maximum inhibitory effect, at a concentration of 100 μM, expressed as a percentage inhibition of nitrite production induced by LPS (1 μg/mL) in the presence of vehicle; ^c^ Positive control. The results are averages of three independent experiments, and the data are expressed as mean ± SD.

3. Experimental
===============

3.1. General
------------

^1^H-, ^13^C-, and 2D-NMR spectra were recorded on a Varian Unity Inova AS 400 FT-NMR instrument, and the chemical shifts were given in δ (ppm) based on the use of tetramethylsilane (TMS) as an internal standard. Optical rotations were measured on a JASCOP-1010 digital polarimeter. IR spectra were run on a Perkin Elmer Spectrum One FT-IR spectrometer. HR-FABMS spectra were obtained using a JEOL JMS-700 mass spectrometer (Tokyo, Japan). A Shimadzu gas chromatograph (GC-14B) equipped with an on-column injection system and flame ionization detector (FID) was used (Tokyo, Japan). Silica gel 60 (Merck, 230--400 mesh), LiChroprep RP-18 (Merck, 40--63 μm), and Sephadex LH-20 (Amersham Pharmacia Biotech., Uppsala, Sweden) were used for column chromatography (CC). Pre-coated silica gel plates (Merck, Kieselgel 60 F~254~, 0.25 mm) and pre-coated RP-18 F~254s~ plates (Merck) were used for analytical thin-layer chromatography analyses. Spots were visualized by spraying with 10% aqueous H~2~SO~4~ solution followed by heating.

3.2. Plant Material
-------------------

The roots of *A. membranaceus* were cultivated in Jecheon, Chungbuk Province, Korea, for one year, harvested in September 2011, and identified by Dr. Jung-Hun Lee, National Institute of Horticultural and Herbal Science (NIHHS), Rural Development Administration (RDA). A voucher specimen (MPS00874) was preserved at the NIHHS, RDA.

3.3. Extraction and Isolation
-----------------------------

The roots of *A. membranaceus* (10 kg) were powdered and extracted three times with 36 L of aqueous 80% MeOH at room temperature for 24 h. After concentration *in vacuo*, the MeOH extract (1,387 g) was suspended in H~2~O (3 L) and then partitioned with EtOAc (3 L × 3) followed by concentration to give the EtOAc fraction (E, 57 g). Fraction E (ARE, 57 g) was subjected to a silica gel CC (10 × 21 cm) using a gradient of CH~2~Cl~2~--MeOH--H~2~O (15:3:1→12:3:1→9:3:1→7:3:1→MeOH, each 2.5 L to yield 23 fractions (E1 to E23). Fraction E10 \[2.51 g, elution volume/total volume (Ve/Vt) 0.45--0.57\] was subjected to the RP-18 silica gel CC \[4.5 × 12 cm, MeOH--H~2~O (1:1.8, 2.5 L)\] to give compound **2** \[184 mg, Ve/Vt 0.43--0.65, (RP-18 F~254s~) R~f~ 0.50, MeOH--H~2~O (5:1)\]. Subfraction E17 (400 mg, Ve/Vt 0.66--0.70) was separated by CC \[RP-18 (4.5 × 8 cm), MeOH--H~2~O (2.5:1, 1.5 L)\] to give compound **4** \[25 mg, Ve/Vt 0.38--0.45, TLC (RP-18 F~254s~) R~f~ 0.30, MeOH--H~2~O (3:1)\]. Fraction E21 \[140 mg, Ve/Vt 0.88--0.92\] was subjected to the RP-18 CC \[3.5 × 7.5 cm, MeOH--H~2~O (3:1) to give five subfractions (E21-1 to E21-5). Subfraction E21-3 (22 mg, Ve/Vt 0.59--0.68) was fractionated using a Sephadex LH 20 CC \[2.5 × 50 cm, MeOH--H~2~O (4:1, 800 L)\] and yielded compound **1** \[12 mg, Ve/Vt 0.66--0.85, TLC (RP-18 F~254s~) Rf 0.40, MeOH--H~2~O (5:1)\]. Subfraction E21-6+7 (45 mg, Ve/Vt 0.59--0.68) was subjected to the RP-18 CC \[2.5 × 7.5 cm, MeOH--H~2~O (3:1) to give compound **5** \[18 mg, Ve/Vt 0.67--0.90, TLC (RP-18 F~254s~) R~f~ 0.35, MeOH--H~2~O (5:1)\]. Fraction E22 \[140 mg, Ve/Vt 0.93--0.98\] was subjected to the RP-18 CC \[3.5 × 6 cm, MeOH--H~2~O (3:1) to give five subfractions (E22-1 to E22-6). Subfraction E22-4 (78 mg, Ve/Vt 0.72--0.81) was fractionated using a RP-18 CC \[2.5 × 5 cm, MeOH--H~2~O (2.5:1, 800 L)\] and yielded compound **3** \[33 mg, Ve/Vt 0.65--0.80, TLC (RP-18 F~254s~) Rf 0.50, MeOH--H~2~O (5:1)\].

3.4. Spectroscopic Data
-----------------------

*Agroastragaloside V* (**1**). Amorphous white powder; ![](molecules-18-03725-i001.jpg) −18.5° (*c* = 0.15, MeOH); IR (CaF~2~ window) cm^−1^: 3433, 1724, 1510, 1245, 1065; HR-FAB/MS *m*/*z* 811.4777 \[M−H\]^−^ (calcd for C43H71O14, 811.4843); ^1^H- and ^13^C-NMR data, see [Table 1](#molecules-18-03725-t001){ref-type="table"}.

3.5. Acid Hydrolysis and GC Analysis
------------------------------------

A solution of compound **1** (3 mg) in 2 N HCl (2 ml) was heated at 80 °C for 6 h. The mixture was cooled at 0 °C and neutralization with 2 N NaOH in H~2~O (2 mL) and then extracted with CHCl~3~. The aqueous layer was concentrated under a vacuum to give a residue of the sugar fraction. The residue was dissolved in pyridine (100 μL), and then 0.1 M L-cysteine methyl ester hydrochloride (150 μL) was added. After reacting at 60 °C for 90 min, the reaction mixture was dried under a vacuum. For derivatization, 100 μL of *N*-methyl-*N*-(trimethylsilyl)trifluoroacetamide (MSTFA) was added and the mixture incubated at 37 °C for 30 min. Then, the mixture was subjected to GC analysis under the following conditions: capillary column, DB-5 (30 m × 0.32 mm × 0.25 μm); detector, FID; detector temperature, 280 °C; injector temperature, 250 °C; carrier, N~2~ gas (20.4 mL/min); oven temperature, 170--250 °C with a rate of 5 °C/min, with one μL of each sample injected directly into the inject port (split-less mode). The peaks from the hydrolyrate of **1** were detected at 9.24 and 10.02 ([d]{.smallcaps}-xylose) and 12.66 min [d]{.smallcaps}-glucose). The retention times for authentic samples in the same experimental conditions were detected at 9.24 and 10.02 ([d]{.smallcaps}-xylose, Sigma), and 12.66 min ([d]{.smallcaps}-glucose, Sigma), respectively.

3.6. Measurement of NO Production and Cell Viability
----------------------------------------------------

Assays for NO production and cell viability were carried out as previously described \[[@B17-molecules-18-03725]\]. Briefly, RAW 264.7 macrophages were harvested and seeded in 24-well plates (3 × 10^5^ cells/well) for the measurement of NO production. The plates were pretreated with various concentrations of samples for 1 h and incubated with LPS (1 μg/mL) for 7 h. The amount of NO was determined by the nitrite concentration in the cultured RAW264.7 macrophage supernatants using the Griess reagent. The cell viability was evaluated by MTT reduction.

4. Conclusions
==============

The new compound 3-*O*-*β*-(2\'-*O*-acetyl)-[d]{.smallcaps}-xylopyranosyl-6-*O*-*β*-[d]{.smallcaps}-glucopyranosyl-(24*S*)-3*β*,6*α*, 24*α*,25-tetrahydroxy-9,19-cyclolanostane, named agroastragaloside V (**1**), was isolated from *Astragalus membranaceus*, together with four known cycloartane glycosides. According to previous investigations of the various *Astragalus* species, we have evaluated the inhibitory activities of all compounds against LPS-induced NO production in RAW264.7 macrophages. Agroastragaloside V and astragaloside IV showed significant inhibition of NO production without cytotoxicity. The results provide a potential explanation for the use of this plant as a herbal medicine in the treatment of inflammatory diseases, and they merit consideration as leads for anti-inflammatory agents.
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*Sample Availability*: Samples of the compounds **1**--**5** are available from the authors.
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Click here for additional data file.

^1^H-NMR, ^13^C-NMR, and HR-FABMS spectra of **1** are available free of charge via the internet at <http://www.mdpi.com/1420-3049/18/4/3725/s1>.
